In this video, Nico Gagelmann, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, discusses the importance of molecular monitoring when treating patients with myelofibrosis (MF) who relapse after stem cell transplantation (SCT), and further highlights the value of donor lymphocyte infusion (DLI) in this patient population. This interview took place at The 8th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM 2023), held in Berlin, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.